Medical Metrics Selected as Imaging Core Lab for Multiple FDA Metal-on-Metal Hip Studies

Medical Metrics, a provider of imaging core lab services for orthopedic clinical trials, has been selected by five leading orthopedic device manufacturers to support multiple cross-sectional post-market FDA surveillance studies of metal-on-metal (MoM) hip implants. MMI will independently evaluate radiographs and MRI to assess long-term outcomes in patients implanted with MoM hips. Over 2,000 subjects will be evaluated at one to 10 years post-implantation.

The goal of these studies is to comply with the FDA’s 522 order requiring manufacturers of MoM hip implants to conduct clinical surveillance of the effect of device wear in implanted patients. (Source: Medical Metrics, Inc.)

RELATED ARTICLES



CONTACT BONEZONE

 

CONTACT BONEZONE